IMNM
Immunome Inc
NASDAQ: IMNM · HEALTHCARE · BIOTECHNOLOGY
$22.95
-3.21% today
Updated 2026-04-29
Market cap
$2.60B
P/E ratio
—
P/S ratio
374.45x
EPS (TTM)
$-2.43
Dividend yield
—
52W range
$7 – $28
Volume
1.2M
Immunome Inc (IMNM) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $4.45M | $5.06M | $44.52M | $57.92M | $24.05M | $148.54M | $240.24M |
| Cash & equivalents | $1.60M | $2.54M | $39.77M | $49.23M | $20.32M | $98.68M | $143.35M |
| Current assets | $2.11M | $3.12M | $42.89M | $56.64M | $22.65M | $144.70M | $221.34M |
| Total liabilities | $29.65M | $40.69M | $3.18M | $9.74M | $7.39M | $28.66M | $59.08M |
| Current liabilities | $1.56M | $1.67M | $3.04M | $9.73M | $7.33M | $21.83M | $54.31M |
| Long-term debt | $325000.00 | $113000.00 | $134000.00 | — | — | — | — |
| Shareholder equity | $-25.20M | $-35.63M | $41.34M | $48.19M | $16.65M | $119.88M | $181.16M |
| Retained earnings | $-26.11M | $-36.56M | $-54.39M | $-79.11M | $-116.00M | $-222.81M | $-515.77M |
| Accounts receivable | — | — | $850000.00 | $4.31M | $847000.00 | $289000.00 | — |
| Inventory | — | — | $-900000.00 | $-4.31M | $-847000.00 | — | — |
| Goodwill | — | — | — | — | — | — | — |